TABLE 1.
Patient characteristics
Characteristics | Comparative dataset | Effect of O2
|
Effect of ACZ
|
||
---|---|---|---|---|---|
Baseline | O2 | Baseline | ACZ | ||
Demographics | |||||
Males/females n/n | 19/9 | 9/2 | 7/5 | ||
Age years | 48±10 | 49±10 | 48±7 | ||
Body mass index kg·m−2 | 35±6 | 34±7 | 34±7 | ||
CPAP cmH2O | 10.9±2.9 | 10.6±2.4 | 10.5±2.0 | ||
Sleep | |||||
Time in bed min | 416±37 | 403±41 | 402±30 | 428±40 | 413±39 |
TST min | 321±51 | 325±55 | 299±57 | 340±42 | 338±44 |
Supine non-REM | 261±63 | 273±60 | 243±65* | 285±68 | 296±52 |
Supine REM | 28±17 | 37±24 | 35±30 | 32±14 | 30±11 |
Respiratory event characteristics | |||||
AHI events·h−1 | 33 (32) | 58 (56) | 42 (38)* | 48 (17) | 25 (20) |
Supine non-REM | 33 (37) | 56 (55) | 42 (43)* | 50 (19) | 24 (22)* |
REM/non-REM | 1.18±0.83 | 1.09±0.84 | 1.38±0.92 | 0.94±0.38 | 1.30±1.10 |
Obstructive apnoea index# events·h−1 | 2.1 (12.6) | 31 (29) | 16 (43) | 4.86 (7.28) | 0.63 (6.21) |
Mixed apnoea index# events·h−1 | 0.00 (0.53) | 0.37 (4.55) | 0.22 (0.60) | 0.00 (0.65) | 0.00 (0.04) |
Central apnoea index# events·h−1 | 0.00 (0.50) | 0.39 (5.32) | 0.00 (0.27)* | 0.00 (0.16) | 0.00 (0.00) |
Hypopnoea index# events·h−1 | 33 (22) | 12 (14) | 11 (11) | 39 (24) | 18 (15) |
Arousal index# events·h−1 | 41 (24) | 60 (44) | 51 (35) | 39 (10) | 32 (7) |
Mean O2 saturation# % | 94±2 | 93±3 | 97±1* | 94±1 | 95±2* |
Minimum O2 saturation# % | 83±6 | 78±7 | 89±4* | 82±4 | 85±5 |
Stable breathing#,¶ % | 18±18 | 14±17 | 14±16 | 10±12 | 20±17 |
Event duration s | 26±6 | 23±4 | 27±5* | 30±10 | 36±10* |
Inter-event interval s | 44±10 | 38±8 | 49±8* | 49±13 | 61±14* |
Ventilatory control | |||||
Standard loop gain+ | 0.57±0.21 | 0.46±0.26§ | 0.32±0.06f | 0.60±0.33 | 0.35±0.21* |
Data are presented as mean±SDor median (interquartile range), unless otherwise stated. ACZ: acetazolamide; CPAP: continuous positive airway pressure; TST: total sleep time; REM: rapid eye movement; AHI: apnoea–hypopnoea index.
measured in supine non-REM sleep
stable breathing (no events or arousals for ≥5 min)
ratio of feedback response to a 1-cycle·min−1 oscillatory disturbance as measured using CPAP drops except for in the O2 study, when proportional ventilation was used in some individuals
proportional assist ventilation used in nine individuals
proportional assist ventilation used in seven individuals.
p<0.05 versus baseline.